NBSE

NeuBase Therapeutics, Inc. Common Stock
NBSE

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

NBSE was delisted on the 10th of May, 2024.

Back to rankings

16 hedge funds and large institutions have $9.62M invested in NeuBase Therapeutics, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

Holders
16
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$7.68M
2
+$218K
3
+$72.3K
4
VF
Virtu Financial
New York
+$64K
5
HWA
Heritage Wealth Advisors
Virginia
+$54K

Top Sellers

1
-$65.7K
2
-$57K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$7.68M
2
$1.28M
3
$205K
4
$104K
5
$86K
6
$79K
7
$64K
8
$54K
9
$37K
10
$19K
11
$2K
12
$2K
13
$1K
14
$1K
15
$1K
16
$1K
17
–